PulseAugur
实时 10:53:31

Genetic evidence strongly linked to drug approval rates, study finds

A new observational analysis of 26,278 target-disease pairs has found that drug targets with genetic associations show a significantly higher approval rate compared to those without. The study, which utilized data from Open Targets and ChEMBL, indicated a 3.25-fold higher approval rate for genetically associated targets. While literature mining accounted for most of the classifier's performance, suggesting potential temporal leakage from post-approval publications, other evidence types still retained a baseline signal. The research also identified 1,433 genetically supported Phase 1/2 pairs as a resource for hypothesis generation, though the classifier's practical predictive value was noted as limited. AI

排序理由 The cluster contains an academic paper published on arXiv detailing research findings. [lever_c_demoted from research: ic=1 ai=0.1]

在 arXiv cs.AI 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

报道来源 [1]

  1. arXiv cs.AI TIER_1 English(EN) · Victoria Paterson ·

    Human genetic evidence is associated with drug approval across therapeutic areas: an observational analysis of 26,278 target-disease pairs with temporal validation and feature ablation

    arXiv:2606.14823v1 Announce Type: cross Abstract: Genetic evidence is enriched among approved drug targets: in an observational analysis of 26,278 target-disease pairs from Open Targets and ChEMBL, targets with any genetic association had a 3.25-fold higher approval rate than tho…